REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 64 filers reported holding REPROS THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $525,000 | +46.2% | 794,913 | -29.2% | 0.00% | – |
| Q3 2017 | $359,000 | -18.4% | 1,122,013 | +17.4% | 0.00% | -100.0% |
| Q2 2017 | $440,000 | -49.6% | 956,013 | +31.5% | 0.00% | 0.0% |
| Q1 2017 | $873,000 | -7.7% | 727,113 | +1.5% | 0.00% | 0.0% |
| Q4 2016 | $946,000 | -32.1% | 716,413 | +7.4% | 0.00% | -50.0% |
| Q3 2016 | $1,394,000 | +54.2% | 667,113 | +18.8% | 0.00% | 0.0% |
| Q2 2016 | $904,000 | +425.6% | 561,713 | +216.1% | 0.00% | – |
| Q1 2016 | $172,000 | +319.5% | 177,713 | +424.0% | 0.00% | – |
| Q4 2015 | $41,000 | -87.7% | 33,913 | -24.5% | 0.00% | -100.0% |
| Q3 2015 | $334,000 | -76.9% | 44,900 | -77.8% | 0.00% | -66.7% |
| Q2 2015 | $1,445,000 | – | 202,143 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,132,367 | $8,096,000 | 1.86% |
| DESTRIER CAPITAL MANAGEMENT LLC | 329,030 | $2,353,000 | 0.56% |
| RTW INVESTMENTS, LP | 229,364 | $1,640,000 | 0.48% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 182,500 | $1,305,000 | 0.41% |
| GENERAL AMERICAN INVESTORS CO INC | 601,553 | $4,301,000 | 0.35% |
| Baker Brothers Advisors | 1,955,944 | $13,985,000 | 0.12% |
| CQS Cayman LP | 240,000 | $1,716,000 | 0.10% |
| Gruss Capital Management LP | 304,000 | $2,174,000 | 0.08% |
| J. Goldman & Co LP | 101,881 | $728,000 | 0.04% |
| Squarepoint Ops LLC | 18,800 | $134,000 | 0.04% |